European CRO for real-world evidence and observational research
OXON Epidemiology is a UK-based Contract Research Organization delivering real-world evidence studies across therapeutic areas for pharma and medical device companies. The tech stack is heavily Microsoft-centric (SAP, Excel, SQL Server, Power BI, Azure) with statistical depth via SAS, Stata, and R—a pattern typical of regulated life sciences orgs where enterprise compliance and data governance sit above velocity. Active projects span hybrid field-database studies, pragmatic trials, and secondary data work; internal pain points flag challenges with complex datasets and IT ecosystem modernization, suggesting the organization is managing growing data complexity with legacy tooling.
OXON Epidemiology operates as a full-service CRO specializing in real-world evidence and observational research across major therapeutic areas. Founded in 2008 and based in London, the organization supports pharmaceutical and medical device companies across the product lifecycle—from regulatory submissions to safety evaluations and health economics analysis. Service lines include multi-country field studies, patient registries, pragmatic trials, PASS/PAES studies, risk management, statistical signal detection, patient-reported outcomes, and systematic reviews. The organization collaborates with academic institutions and life sciences partners to deliver primary, secondary, and hybrid data studies with regulatory compliance and scientific rigor.
Microsoft enterprise stack (SAP, SQL Server, Power BI, Azure, 365), statistical tools (SAS, Stata, R), and development languages (JavaScript, TypeScript, HTML5, CSS). SharePoint and Power Apps handle internal workflows.
Current projects include hybrid field-database studies, pragmatic trials, international observational field studies, and secondary data studies. Internal focus includes SharePoint-based application development and business process support.
Other companies in the same industry, closest in size